Cargando…
An Update on the Chemokine System in the Development of NAFLD
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world. Sustained hepatic inflammation is a key driver of the transition from simple fatty liver to nonalcoholic steatohepatitis (NASH), the more aggressive form of NAFLD. Hepatic inflammation is orchestrated by...
Autores principales: | Nagata, Naoto, Chen, Guanliang, Xu, Liang, Ando, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227560/ https://www.ncbi.nlm.nih.gov/pubmed/35744024 http://dx.doi.org/10.3390/medicina58060761 |
Ejemplares similares
-
Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
por: Chen, Guanliang, et al.
Publicado: (2016) -
The role of NAFLD in cardiometabolic disease: an update
por: Faasse, Sarah, et al.
Publicado: (2018) -
Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
por: Shao, Yaodi, et al.
Publicado: (2023) -
Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development
por: Kriss, Michael, et al.
Publicado: (2020) -
Role of B Lymphocytes in the Pathogenesis of NAFLD: A 2022 Update
por: Deng, Chu-Jun, et al.
Publicado: (2022)